A newly-crowned champion, the UFC and an athletic commission can breathe a sigh of relief.
Jon Jones had his knockout win over Daniel Cormier at UFC 214 in 2017 overturned to a no-contest after he tested positive for turinabol. It wasn’t his first offence, following a similar scenario prior to UFC 200 a year previous.
With Cormier set to vacate his light heavyweight belt, Jones earned a title shot against Alexander Gustafsson with the bout set to take place in Las Vegas at UFC 232 last month.
But on December 9, a USADA drug test found that he tested positive for a trace amount of M3 metabolite, a picogram to be exact.
It was claimed to be a leftover from his previous failed test, but in order for the fight to go ahead, the UFC took the unprecedented step to move the pay-per-view to California instead just a week before, with sanctioning by the NSAC becoming an issue.
Jones won the fight and the title at The Forum in Inglewood, CA., but much of the credibility of the CSAC rested on no further offences occurring.
Luckily for them and all parties involved, Jones has returned multiple clean drug tests in the wake of his TKO win over Gustafsson.
Andy Foster of the CSAC told Brett Okamoto of ESPN that in addition to the customary USADA test, his commission also tested ‘Bones’, with both tests confirmed as negative.
Breaking: Jon Jones was drug tested by USADA and the California State Athletic Commission on the night of UFC 232 on Dec. 29 and all tests have come back clean. No picograms of the M3 metabolite, which was the source of all the controversy and drama last month, were found.
— Brett Okamoto (@bokamotoESPN) January 10, 2019
Confusion still reigns however, with the statement claiming that the controversial picogram of material may take years to leave Jones’ system running contrary to these clean tests.
The hope for the UFC now is that the rogue item doesn’t resurface in future, beginning with Jones’ expected title defence against Anthony Smith in March at UFC 235.